Daniel Cuadras Selected Research

Cerebellar Diseases (Cerebellar Syndrome)

1/2019	AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
12/2018	Clinical Assessment of Dysarthria in Children with Cerebellar Syndrome Associated with PMM2-CDG.
2/2018	Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.
1/2017	A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG).
10/2015	Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Cuadras Research Topics

Disease

5	Cerebellar Diseases (Cerebellar Syndrome) 01/2019 - 10/2015
4	Neoplasms (Cancer) 01/2022 - 04/2011
4	Ataxia (Dyssynergia) 12/2018 - 10/2015
4	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2011
3	Atrophy 01/2017 - 10/2015
2	Epilepsy (Aura) 01/2022 - 01/2020
2	Infections 12/2021 - 05/2015
2	Scoliosis 03/2021 - 01/2020
2	Carcinogenesis 01/2021 - 01/2013
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Schizophrenia (Dementia Praecox) 09/2020 - 03/2016
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2019 - 10/2015
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2015
1	Biliary Atresia 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Coinfection 12/2021
1	Hypoxia (Hypoxemia) 11/2021
1	Friedreich Ataxia (Friedreich's Ataxia) 11/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 03/2021
1	Muscle Weakness 03/2021
1	Macrophage Activation Syndrome 01/2021
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2021
1	Bacterial Infections (Bacterial Infection) 10/2020
1	Neuroinflammatory Diseases 10/2020
1	Neurobehavioral Manifestations 09/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2020
1	Sleep Wake Disorders 09/2019
1	Asthenia 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Cognitive Dysfunction 01/2019
1	Dysarthria (Spastic Dysarthria) 12/2018
1	Obesity 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Intussusception 04/2018
1	Stroke (Strokes) 02/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 02/2018
1	Channelopathies 02/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2018
1	Neurodevelopmental Disorders 01/2018
1	succinic semialdehyde dehydrogenase deficiency 01/2018
1	Contusions 03/2017
1	Retinal Detachment (Retinal Detachments) 03/2017
1	Ectopia Lentis 03/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Hyperprolactinemia 10/2016
1	Aphasia (Dysphasia) 03/2016

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
7	phosphomannomutaseIBA 01/2019 - 10/2015
6	Congenital disorder of glycosylation type 1AIBA 01/2019 - 10/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2018
2	Raloxifene Hydrochloride (Evista)FDA Link 09/2020 - 03/2016
2	voltage-dependent calcium channel (P-Q type)IBA 01/2019 - 02/2018
2	glucose-regulated proteinsIBA 01/2017 - 12/2015
2	Antipsychotic Agents (Antipsychotics)IBA 10/2016 - 03/2016
1	AcidsIBA 01/2022
1	Hydroxyindoleacetic AcidIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	idebenoneIBA 11/2021
1	CatecholaminesIBA 11/2021
1	nusinersenIBA 03/2021
1	Clorgyline (Clorgiline)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	Chemokine CCL5IBA 01/2021
1	Loratadine (Alavert)FDA Link 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	CytokinesIBA 01/2021
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	lipoarabinomannan (LAM)IBA 01/2021
1	rasagiline (Azilect)FDA Link 01/2021
1	NeopterinIBA 10/2020
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Laminin (Merosin)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 09/2019
1	Serotonin (5 Hydroxytryptamine)IBA 09/2019
1	MelatoninIBA 09/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Choline (Choline Chloride)IBA 10/2018
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2017

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Enema (Enemas) 04/2018
1	Vitrectomy 03/2017
1	Intraocular Lenses (Intraocular Lens) 03/2017
1	Intraocular Lens Implantation 03/2017